HK1259323A1 - 治療、預防和診斷豬流行性腹瀉病毒感染的方法 - Google Patents

治療、預防和診斷豬流行性腹瀉病毒感染的方法

Info

Publication number
HK1259323A1
HK1259323A1 HK19101689.3A HK19101689A HK1259323A1 HK 1259323 A1 HK1259323 A1 HK 1259323A1 HK 19101689 A HK19101689 A HK 19101689A HK 1259323 A1 HK1259323 A1 HK 1259323A1
Authority
HK
Hong Kong
Prior art keywords
treating
preventing
methods
virus infection
diarrhea virus
Prior art date
Application number
HK19101689.3A
Other languages
English (en)
Inventor
Volker Gerdts
Brenda Allan
Den Hurk Jan Van
Yan Zhou
Alexander Zakhartchouk
Suresh Tikoo
Andrew Potter
Original Assignee
The Univ Of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Univ Of Saskatchewan filed Critical The Univ Of Saskatchewan
Publication of HK1259323A1 publication Critical patent/HK1259323A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G01N2333/17—Porcine transmissible gastroenteritis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK19101689.3A 2015-11-25 2019-01-30 治療、預防和診斷豬流行性腹瀉病毒感染的方法 HK1259323A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562260128P 2015-11-25 2015-11-25
US201662382395P 2016-09-01 2016-09-01
PCT/CA2016/051381 WO2017088060A1 (en) 2015-11-25 2016-11-24 Methods for treating, preventing and diagnosing porcine epidemic diarrhea virus infection

Publications (1)

Publication Number Publication Date
HK1259323A1 true HK1259323A1 (zh) 2019-11-29

Family

ID=58762804

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101689.3A HK1259323A1 (zh) 2015-11-25 2019-01-30 治療、預防和診斷豬流行性腹瀉病毒感染的方法

Country Status (9)

Country Link
US (1) US20180344836A1 (zh)
EP (1) EP3380494A4 (zh)
BR (1) BR112018010679A8 (zh)
CA (1) CA3004931A1 (zh)
HK (1) HK1259323A1 (zh)
MX (1) MX2018006416A (zh)
RU (1) RU2018123005A (zh)
TW (1) TW201731525A (zh)
WO (1) WO2017088060A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486067B (zh) * 2018-02-11 2022-03-15 黑龙江正康生物技术股份有限公司 猪流行性腹泻病毒变异株及其制备的灭活疫苗和应用
CN109337876A (zh) * 2018-10-15 2019-02-15 北京世纪元亨动物防疫技术有限公司 一种猪流行性腹泻病毒的纯化方法
WO2020172757A1 (en) * 2019-02-28 2020-09-03 University Of Saskatchewan Lawsonia intracellularis compositions and methods of using the same
CN111474346B (zh) * 2020-04-15 2023-07-11 浙江理工大学绍兴生物医药研究院有限公司 猪流行性腹泻病毒IgA和IgG抗体检测试剂盒及其制备方法和应用
CN112415207B (zh) * 2020-10-27 2022-04-12 中国农业科学院兰州兽医研究所 一种基于抗猪流行性腹泻病毒变异毒株重组S2蛋白的IgA抗体ELISA检测试剂盒
TWI829223B (zh) * 2021-07-08 2024-01-11 中央研究院 重組抗體及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ591925A (en) * 2008-10-16 2012-09-28 Internat Vaccine Inst Adjuvant composition comprising a host defense peptide, an immunostimulatory sequence and a polyanionic polymer
CN103675274B (zh) * 2013-12-17 2016-03-30 广西大学 检测猪流行性腹泻病毒抗体的间接elisa试剂盒
EP3125932A1 (en) * 2014-04-03 2017-02-08 Boehringer Ingelheim Vetmedica, Inc. Porcine epidemic diarrhea virus vaccine
US9713639B2 (en) * 2014-05-19 2017-07-25 Merial, Inc. Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
HUE056025T2 (hu) * 2014-07-11 2022-01-28 Zoetis Services Llc Új oltóanyag-készítmények sertések járványos hasmenésének vírusa ellen
CN104262488B (zh) * 2014-09-24 2017-07-28 普莱柯生物工程股份有限公司 一种融合蛋白及其疫苗组合物的制备与应用

Also Published As

Publication number Publication date
EP3380494A4 (en) 2019-11-13
CA3004931A1 (en) 2017-06-01
WO2017088060A1 (en) 2017-06-01
RU2018123005A (ru) 2019-12-25
EP3380494A1 (en) 2018-10-03
BR112018010679A2 (pt) 2018-11-13
RU2018123005A3 (zh) 2020-04-09
TW201731525A (zh) 2017-09-16
BR112018010679A8 (pt) 2019-02-26
MX2018006416A (es) 2018-11-09
US20180344836A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
HK1258795A1 (zh) 絲狀病毒科病毒感染的治療方法
HK1259323A1 (zh) 治療、預防和診斷豬流行性腹瀉病毒感染的方法
SI3349758T1 (sl) Postopki za zdravljenje okužb z virusom arenaviridae
IL282881A (en) Methods for treating hepatitis B infection
EP3139954A4 (en) Methods and compositions for treating hepatitis b virus infections
PL3421993T3 (pl) Metoda diagnostyczna i urządzenie do jej przeprowadzania
SG11201808246SA (en) Methods for treating and preventing c. difficile infection
IL271728A (en) Materials, uses and treatment methods
EP3166637A4 (en) Compositions and methods for treating dengue virus infection
ZA201907283B (en) Compositions, devices and methods for treating autism
IL246643B (en) Preparations and kits for the treatment of immunodeficiency virus/acquired immunodeficiency syndrome
HK1246196A1 (zh) 用於治療艱難梭菌(clostridium difficile)感染和相關疾病的方法
EP2969006A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFECTION WITH IMMUNODEFICIENCY VIRUSES
PL3473631T3 (pl) Nowe alkoksysilany z epoksydowymi grupami funkcyjnymi, sposób ich wytwarzania i ich zastosowanie
EP3322481A4 (en) TREATMENT OF ROTATOR COIL DRESSES
EP3232362A4 (en) Leakage prevention device, leakage prevention method, and program
IL265651B (en) Method for operating an inverter, and inverter
ZA202000943B (en) Methods for treating hcv
GB201707839D0 (en) Attenuated virus
GB201615311D0 (en) Virus, Vaccine cures
GB201521639D0 (en) An exhaust after treatment device
AU2015900546A0 (en) Agents and methods for inhibiting virus infection
AU2014900488A0 (en) Agents and methods for inhibiting virus infection